GMP Regulatory Update: MHRA, FDA & AI | Edition 34
GMP and GDP update covering MHRA recalls, FDA warning letters, EMA Annex 22 AI in GMP, medicine shortages and practical audit-readiness learning.
Read the editionBrowse the W2 archive of GMP and GDP newsletter editions. Each edition reflects its original publication context; check the current primary source before acting on regulatory updates.
GMP and GDP update covering MHRA recalls, FDA warning letters, EMA Annex 22 AI in GMP, medicine shortages and practical audit-readiness learning.
Read the editionGMP and GDP update covering lifecycle control, data integrity, reference samples, AI in GMP, medicine shortages and supply-chain integrity.
Read the editionGMP and GDP update covering AI regulation, medicine authorisations, labelling defects, FDA CGMP enforcement and distribution controls.
Read the editionGMP and GDP regulatory update covering product quality, medicine shortages, supply-chain integrity, inspection awareness and audit readiness.
Read the editionGMP update covering Annex 6 and Annex 15 developments, quality maturity, medicine recalls, sampling controls and practical compliance learning.
Read the editionGMP update covering validation, Annex 1, data integrity, medicine recalls, QAAPS and inspection-ready change-control governance.
Read the editionGMP update covering ICH Q3E, EU regulatory variations, medicine recalls, NHS aseptic services, audit readiness and compliance learning.
Read the editionGMP update covering pharmaceutical quality news, regulator developments, global recalls, NHS aseptic services and practical audit readiness.
Read the editionTell us what you are planning or working through. We’ll help you make sense of the next step and agree where we can support your team.